Butaclamol
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C25H31NO |
Molar mass | 361.52 g/mol |
3D model (Jmol) | |
|
Butaclamol (AY-23,028) is an antipsychotic which was never marketed.[1] Sold as the hydrochloride salt for use in research, the compound acts as a dopamine receptor antagonist.[2]
Chemistry[edit]
pKa = 7.15 (uncorrected for ionic strength)[3]
See also[edit]
References[edit]
- ^ Buckingham, J. Dictionary of organic compounds - Google Books. ISBN 9780412540905.
- ^ http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&N5=SEARCH_CONCAT_PNO%7CBRAND_KEY&N4=D033%7CSIGMA&N25=0&QS=ON&F=SPEC
- ^ F. A. Chrzanowski, B. A. McGrogan, B. E. Maryanoff (1985). "The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptors." J. Med. Chem. 28 399-400.
Classes | |
---|---|
Antidepressants (TCAs and TeCAs) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Others |
|
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |